The effects of pomegranate consumption on blood pressure in adults: A systematic review and meta‐analysis

Hossein Bahari,Kosar Omidian,Kian Goudarzi,Hossein Rafiei,Omid Asbaghi,Kosar Sadat Hosseini Kolbadi,Moslem Naderian,Ali Hosseini
DOI: https://doi.org/10.1002/ptr.8170
IF: 6.388
2024-02-28
Phytotherapy Research
Abstract:Considering the main component of cardiovascular disease and due to the high prevalence of hypertension, controlling blood pressure is required in individuals with various health conditions. Randomized clinical trials (RCTs) which studied the effects of pomegranate consumption on blood pressure have shown inconsistent findings. As a result, we intended to assess the effects of pomegranate consumption on systolic (SBP) and diastolic (DBP) blood pressure in adults. Systematic literature searches up to January 2024 were carried out using electronic databases, including PubMed, Web of Science, and Scopus, to identify eligible RCTs assessing the effects of pomegranate on blood pressure as an outcome. All the individuals who took part in our research were adults who consumed pomegranate in different forms as part of the study intervention. Heterogeneity tests of the selected trials were performed using the I2 statistic. Random effects models were assessed based on the heterogeneity tests, and pooled data were determined as the weighted mean difference (WMD) with a 95% confidence interval (CI). Of 2315 records, 22 eligible RCTs were included in the current study. Our meta‐analysis of the pooled findings showed that pomegranate consumption significantly reduced SBP (WMD: −7.87 mmHg; 95% CI: −10.34 to −5.39; p 130 mmHg had a significantly greater reduction in SBP compared to individuals with baseline SBP
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?